The American Cancer Society (ACS) concludes that the benefits of PSA-based screening for prostate cancer outweigh the harms, recommending biennial…
An updated Cochrane systematic review of five randomized controlled trials involving 341,342 men found that PSA-based prostate cancer screening did…
A prospective multicenter cohort study revealed that protocol-directed active surveillance is safe and effective for avoiding overtreatment and preventing undertreatment…
This website uses cookies.